Curie: Healthcare in Focus

Love what you hear? Download the Curie app from the App Store for expert-driven healthcare content tailored to your interests . The National Institutes of Health (NIH) has long been the backbone of U.S. biomedical research—but a new wave of budget cuts could change that. With $4 billion in funding on the line, clinical trials are at risk, research programs are in limbo, and top scientists may star...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Retirement isn’t what it used to be—especially for physicians. With financial pressures, a deep sense of professional identity, and a worsening physician shortage,...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt breaks down three major updates in oncology. ASCO has released updated guidelines for advanced ovarian cancer, emphasizing primary...

Love what you hear? Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Download the Curie app from the App Store today. COVID-19 conspiracy theories aren’t just lingering—they’re growing, evolving, and shaping how patients interact with medicine. In this episode of Curie, Matt unpack...

You can download the Curie app from the App Store here for more expert-driven healthcare related content. H5N1 has spread to dairy cattle—and human infections are following. What does this mean for medicine and public health? In this episode of Curie , Matt unpacks the rise of bird flu in 2025, the latest case numbers, and whether this new variant is a pandemic threat.

Pharma is making its way onto the biggest advertising stage of the year—the Super Bowl. But should these ads be part of the spectacle? In this episode of Curie, Matt investigates why more pharmaceutical brands are investing in high-profile TV spots, the ethics of direct-to-consumer drug marketing, and what this means for healthcare professionals navigating patient conversations.

ASCO GI 2025 delivered big wins in gastrointestinal oncology. We highlight key findings, including nivolumab-plus-ipilimumab in MSI-H mCRC, encorafenib-based regimens for BRAF-mutant CRC, and innovative strategies in CAR-T therapies. Catch up on the most impactful data shaping the future of cancer care. Like what you hear? Download Curie from App Store for more in-depth insights in onlcology and g...

Trump’s second term is already bringing massive changes to U.S. healthcare—Medicaid funding freezes, ACA rollbacks, and an exit from the WHO. What does it mean for physicians, hospitals, and public health? Matt breaks down the sweeping policies reshaping American medicine. If you find this episode insightful, download the Curie app from the App Store for more expert-driven healthcare content

What happens when the U.S. steps away from global health leadership? In this episode of Curie , Matt explores the potential consequences of leaving the WHO, from vaccine development disruptions to the growing influence of other nations in global health policy. If you enjoy this episode, download the Curie app from the App Store for more in-depth healthcare insights.

How will the FDA’s latest policies change the way we eat, smoke, and think about health? Join Matt and Lisa on Curie as they unpack the ban on Red Dye No. 3, the push to cut nicotine in cigarettes, and new front-of-package nutrition labels. If you enjoy this episode, download the Curie app from the App Store for more curated healthcare content.

Electronic health records promised to transform healthcare, but are they doing more harm than good? In this episode of Curie, we dive into how EHRs contribute to physician burnout, explore the hidden costs to patient care, and discuss solutions to reclaim their promise. If you find this episode valuable, download the Curie app from the App Store for more curated healthcare content.

Physicians are working harder than ever, but is their pay keeping up? In this episode of Curie, we delve into the 2024 Physician Compensation Report, unpacking salary trends, persistent gender pay gaps, and the challenges facing medical professionals. If you find this episode valuable, download the Curie app on the App Store for more curated healthcare insights.

Like what you hear? Download Curie , your go-to app for curated healthcare podcasts. In this episode of Curie, we explore why healthcare professionals are flocking to Bluesky—a social media platform offering a refreshing alternative to X. Discover the features driving this migration, the challenges of digital networking, and what it means for the future of professional collaboration.

The ASH 2024 wrap-up is here! We’re spotlighting the most impactful developments, including menin inhibitors redefining AML treatment, promising gene-editing therapies for sickle cell disease, and next-gen CAR-T advances. Don’t miss this final episode! Like what you hear? Download Curie from the App store for personalized insights.

The shocking death of UnitedHealthcare CEO Brian Thompson has sparked outrage and reflection on the state of American healthcare. In this episode, Curie host Matt investigates the deeper questions: Why do so many Americans feel betrayed by their insurers? How do profit-driven motives in healthcare create systemic failures? We break down the numbers, including UnitedHealthcare’s industry-high claim...

On Day 4 of ASH 2024, explore the remarkable 96% disease-free survival with Blincyto in pediatric ALL, deep responses with Epcoritamab in relapsed CLL, and the promise of a next-gen BCL2 inhibitor in a potent CLL combination. Tune in for transformative insights! Like what you hear? Download Curie from the App store for personalized insights.

Day 3 of ASH 2024 revealed groundbreaking findings: a 97% complete response rate for zilovertamab vedotin in diffuse large B-cell lymphoma, new insights into zanubrutinib’s efficacy in chronic lymphocytic leukemia, and promising survival data for belantamab mafodotin in multiple myeloma. Like what you hear? Download Curie from the App Store for more personalized healthcare content.

On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice. Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology profe...

Day 1 of ASH 2024 brought exciting advancements in hematology. In this episode, we explore highlights from pivotal trials, including etavopivat’s impact on sickle cell disease, rilzabrutinib’s rapid platelet response in ITP, and hydroxyurea’s benefits for HbSC patients. Hosted by Matt, this podcast offers clear insights into the research shaping tomorrow’s treatments. Love what you hear? Download...

Prepare for ASH 2024 with this in-depth preview! In this episode, Matt dives into the conference’s overarching themes, from artificial intelligence and cellular therapies to health equity and novel drug advancements. He also shares practical tips to help you make the most of the event. Like what you hear? Download Curie from the App store for personalized insights.

Robert F. Kennedy Jr.’s nomination as Secretary of Health and Human Services has sparked intense debate. In this episode, we explore his controversial stances on vaccines, fluoride, and public health, his ambitious reform agenda, and the potential implications for America’s health policy. Enjoyed the episode? Download the Curie app here to personalize your listening experience. Get two exclusive e...